InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,660.00
(
0.33%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.01
(
0.07%
)
Bitcoin
62,786.89
(
-0.41%
)
Post# of 13741
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jedijazz

Send PM Follow Ignore
Followers 1322
Posts 247394
Boards Moderated 55
Alias Born 12/07/2009

jedijazz

Member Level

Re: ProfitScout post# 11812

Wednesday, 01/19/2022 11:19:22 PM

Wednesday, January 19, 2022 11:19:22 PM

Post# of 13741
"End of January, the Company also plans to request a meeting with the United States (“US”) Food & Drug Administration (“FDA”) in order to explore the possibility of a change from PIND to IND status and approving Escozine for a 30-to-60 patient pilot study to show proof of concept within the US." $QNTA


ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up